Human ABC transporters ABCG2 (BCRP) and ABCG4
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
1. The human ABC transporter ABCG2 is regarded as a member of the phase III system for xenobiotic metabolism, and it has been suggested that this efflux pump is responsible for protecting the body from toxic xenobiotics and for removing metabolites. 2. This review paper will address the new aspects of ABCG2 in terms of post-translational modifications (i.e., disulfide bond formation, ubiquitination, and endoplasmic reticulum-associated degradation) of ABCG2 protein, high-speed screening, and quantitative structure-activity relationship (QSAR) analysis to evaluate ABCG2-drug interactions, and genetic polymorphisms potentially associated with photosensitivity. 3. In addition, new aspects of human ABCG4 and mouse Abcg4 are presented with respect to their molecular properties and potential physiological roles. Considering a high sequence similarity between ABCG1 and ABCG4, both Abcg4 and ABCG4 may be involved in the transport of cholesterol from neurons and astrocytes. Furthermore, high expression of the mouse Abcg4 protein in the testis implicates its involvement in transport of certain sex hormones.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhou, S., Schuetz, J. D., Bunting, K. D., Colapietro, A.-M., Sampath, J., Morris, J. J., Lagutina, I., Grosveld, G. C., Osawa, M., Nakauchi, H., et al. (2001) · Nature Medicine · doi:10.1038/nm0901-1028 · Cited by 2,280
Aggresomes: A Cellular Response to Misfolded Proteins
Johnston, J. A., Ward, C. L., & Kopito, R. R. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.7.1883 · Cited by 2,148 · cited 2×
“Aggresome formation has also been reported for misfolded cystic fibrosis transmembrane conductance regulator (CFTR) proteins (Johnston et al. 1998).”
BackgroundOxidized Redox State of Glutathione in the Endoplasmic Reticulum
Hwang, C., Sinskey, A. J., & Lodish, H. F. (1992) · Science · doi:10.1126/science.1523409 · Cited by 1,968 · cited 3×
“2004), it has recently been shown that disulfide formation is driven by a protein relay involving endoplasmic reticulum oxidase 1 (Ero1), a novel FAD-dependent enzyme, and protein disulfide isomerase (PDI) (Hwang et al. 1992; Tu and Weissman 2004).”
BackgroundInfluentialOxidative protein folding in eukaryotes
Tu, B. P., & Weissman, J. S. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200311055 · Cited by 1,041
Jonker, J. W., Buitelaar, M., Wagenaar, E., van der Valk, M. A., Scheffer, G. L., Scheper, R. J., Plösch, T., Kuipers, F., Elferink, R. P. J. O., Rosing, H., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202607599 · Cited by 822
ABCG2-mediated transport of photosensitizers: Potential impact on photodynamic therapy
Robey, R. W., Steadman, K., Polgar, O., & Bates, S. E. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.2.1440 · Cited by 204 · cited 2×
“It has been suggested that overexpression of ABCG2 can enhance the elimination of those photosensitizers from cancer cells, thereby conferring them with resistance to photodynamic therapy (Robey et al. 2005).”
BackgroundKim, W. S., Rahmanto, A. S., Kamili, A., Rye, K.-A., Guillemin, G. J., Gelissen, I. C., Jessup, W., Hill, A. F., & Garner, B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607831200 · Cited by 191
Zhou, S., Zong, Y., Ney, P. A., Nair, G., Stewart, C. F., & Sorrentino, B. P. (2005) · Blood · doi:10.1182/blood-2004-04-1566 · Cited by 157
Tamura, A., Watanabe, M., Saito, H., Nakagawa, H., Kamachi, T., Okura, I., & Ishikawa, T. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.023556 · Cited by 141
Self-citationSaito, H., Hirano, H., Nakagawa, H., Fukami, T., Oosumi, K., Murakami, K., Kimura, H., Kouchi, T., Konomi, M., Tao, E., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.099036 · Cited by 92
Self-citation
Cited by
The Blood-Testis Barrier and Its Implications for Male Contraception
Cheng, C. Y., & Mruk, D. D. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.002790 · Cited by 927
Blood–brain barrier structure and function and the challenges for CNS drug delivery
Abbott, N. J. (2013) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-013-9608-0 · Cited by 909
Tebay, L. E., Robertson, H., Durant, S. T., Vitale, S. R., Penning, T. M., Dinkova-Kostova, A. T., & Hayes, J. D. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.021 · Cited by 837
“Drug metabolism occurs in three phases, which act to make lipophilic xenobiotics more water soluble, to render them less harmful, and finally to export them from the cell [52].”
Direct evidence of abca1-mediated efflux of cholesterol at the mouse blood–brain barrier
Do, T. M., Ouellet, M., Calon, F., Chimini, G., Chacun, H., Farinotti, R., & Bourasset, F. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0910-6 · Cited by 36
An, R., Hagiya, Y., Tamura, A., Li, S., Saito, H., Tokushima, D., & Ishikawa, T. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9738-5 · Cited by 34
Self-citation
Metadata
- Authors
- Koshiba, S., An, R., Saito, H., Wakabayashi, K., Tamura, A., & Ishikawa, T.
- Venue
- Xenobiotica
- Publisher
- Informa UK Limited
- Published
- 2008-08
- Volume
- 38
- Issue
- 7-8
- Pages
- 863-888
- ISSN
- 0049-8254 (ISSN-L)
- 1366-5928
- OpenAlex
- W1980673745
- Cited by
- 47
- References
- 10
- FWCI
- 2.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human ABC transporters ABCG2 (BCRP) and ABCG4. https://app.cochat.ai/papers/10.1080/00498250801986944
- The paper
- Koshiba, S., An, R., Saito, H., Wakabayashi, K., Tamura, A., & Ishikawa, T. (2008). Human ABC transporters ABCG2 (BCRP) and ABCG4. Xenobiotica. https://doi.org/10.1080/00498250801986944
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.